167 related articles for article (PubMed ID: 1563808)
1. Effect of subinhibitory concentrations of antibiotics on extracellular Shiga-like toxin I.
Walterspiel JN; Ashkenazi S; Morrow AL; Cleary TG
Infection; 1992; 20(1):25-9. PubMed ID: 1563808
[TBL] [Abstract][Full Text] [Related]
2. Strain-specific differences in the amount of Shiga toxin released from enterohemorrhagic Escherichia coli O157 following exposure to subinhibitory concentrations of antimicrobial agents.
Grif K; Dierich MP; Karch H; Allerberger F
Eur J Clin Microbiol Infect Dis; 1998 Nov; 17(11):761-6. PubMed ID: 9923515
[TBL] [Abstract][Full Text] [Related]
3. Isolation of an Escherichia coli O157:H7 strain producing Shiga toxin 1 but not Shiga toxin 2 from a patient with hemolytic uremic syndrome in Korea.
Kim YB; Okuda J; Matsumoto C; Morigaki T; Asai N; Watanabe H; Nishibuchi M
FEMS Microbiol Lett; 1998 Sep; 166(1):43-8. PubMed ID: 9741083
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial resistance of Shiga toxin (verotoxin)-producing Escherichia coli O157:H7 and non-O157 strains isolated from humans, cattle, sheep and food in Spain.
Mora A; Blanco JE; Blanco M; Alonso MP; Dhabi G; Echeita A; González EA; Bernárdez MI; Blanco J
Res Microbiol; 2005 Aug; 156(7):793-806. PubMed ID: 15921895
[TBL] [Abstract][Full Text] [Related]
5. Effect of antibiotics on cellular stress generated in Shiga toxin-producing Escherichia coli O157:H7 and non-O157 biofilms.
Angel Villegas N; Baronetti J; Albesa I; Etcheverría A; Becerra MC; Padola NL; Paraje MG
Toxicol In Vitro; 2015 Oct; 29(7):1692-700. PubMed ID: 26130220
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of antibiotic therapy for infection with Shiga-like toxin-producing Escherichia coli O157:H7 in mice with protein-calorie malnutrition.
Kurioka T; Yunou Y; Harada H; Kita E
Eur J Clin Microbiol Infect Dis; 1999 Aug; 18(8):561-71. PubMed ID: 10517193
[TBL] [Abstract][Full Text] [Related]
7. Hemolytic uremic syndrome and diarrhea in Argentine children: the role of Shiga-like toxins.
Lopez EL; Diaz M; Grinstein S; Devoto S; Mendilaharzu F; Murray BE; Ashkenazi S; Rubeglio E; Woloj M; Vasquez M
J Infect Dis; 1989 Sep; 160(3):469-75. PubMed ID: 2668430
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis of infections with Shiga-like toxin-producing Escherichia coli by use of enzyme-linked immunosorbent assays for Shiga-like toxins on cultured stool samples.
Law D; Hamour AA; Acheson DW; Panigrahi H; Ganguli LA; Denning DW
J Med Microbiol; 1994 Apr; 40(4):241-5. PubMed ID: 8151673
[TBL] [Abstract][Full Text] [Related]
9. Hemolytic uremic syndrome: co-infection with two different serotypes of Shiga-like toxin producing Escherichia coli.
Rivas M; Voyer L; Tous M; Leardini N; de Mena MF; Wainsztein R; Callejo R; Prado V; Binsztein N
Medicina (B Aires); 1993; 53(6):487-90. PubMed ID: 8084244
[TBL] [Abstract][Full Text] [Related]
10. Association between hemolytic uremic syndrome and verotoxin-producing strains of E. coli.
Jure MA; de Saab OA; de Castillo MC; Sesma F; Miceli S; Zamora AM; de Ruiz Holgado AP; de Nader OM
Rev Latinoam Microbiol; 1998; 40(1-2):1-8. PubMed ID: 10932728
[TBL] [Abstract][Full Text] [Related]
11. Low-level release of Shiga-like toxin (verocytotoxin) and endotoxin from enterohemorrhagic Escherichia coli treated with imipenem.
Takahashi K; Narita K; Kato Y; Sugiyama T; Koide N; Yoshida T; Yokochi T
Antimicrob Agents Chemother; 1997 Oct; 41(10):2295-6. PubMed ID: 9333067
[TBL] [Abstract][Full Text] [Related]
12. Enterohemorrhagic Escherichia coli Hybrid Pathotype O80:H2 as a New Therapeutic Challenge.
Soysal N; Mariani-Kurkdjian P; Smail Y; Liguori S; Gouali M; Loukiadis E; Fach P; Bruyand M; Blanco J; Bidet P; Bonacorsi S
Emerg Infect Dis; 2016 Sep; 22(9):1604-12. PubMed ID: 27533474
[TBL] [Abstract][Full Text] [Related]
13. Diarrhea in young children associated with Escherichia coli non-O157 organisms that produce Shiga-like toxin.
Huppertz HI; Busch D; Schmidt H; Aleksic S; Karch H
J Pediatr; 1996 Mar; 128(3):341-6. PubMed ID: 8774501
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional and Translational Inhibitors Block SOS Response and Shiga Toxin Expression in Enterohemorrhagic Escherichia coli.
Berger M; Aijaz I; Berger P; Dobrindt U; Koudelka G
Sci Rep; 2019 Dec; 9(1):18777. PubMed ID: 31827185
[TBL] [Abstract][Full Text] [Related]
15. Rifaximin does not induce toxin production or phage-mediated lysis of Shiga toxin-producing Escherichia coli.
Ochoa TJ; Chen J; Walker CM; Gonzales E; Cleary TG
Antimicrob Agents Chemother; 2007 Aug; 51(8):2837-41. PubMed ID: 17526759
[TBL] [Abstract][Full Text] [Related]
16. Evidence of infection with organisms producing Shiga-like toxins in household contacts of children with the hemolytic uremic syndrome.
Lopez EL; Diaz M; Devoto S; Grinstein S; Woloj M; Murray BE; Rubeglio E; Mendilaharzu F; Turco M; Vasquez M
Pediatr Infect Dis J; 1991 Jan; 10(1):20-4. PubMed ID: 2003052
[TBL] [Abstract][Full Text] [Related]
17. [Enterohemorrhagic Escherichia coli in hemolytic uremic syndrome in Chilean children. Evaluation of different technics in the diagnosis of the infection].
Prado V; Cordero J; Garreaud C; Olguin H; Arellano C; Nachar CL; Misraji A; Martínez J; Tous M; Rivas M
Rev Med Chil; 1995 Jan; 123(1):13-22. PubMed ID: 7569441
[TBL] [Abstract][Full Text] [Related]
18. Examination of verocytotoxin producing capacity and determination of the presence of Shiga-like toxin genes in human Escherichia coli isolates.
Tóth I; Karcagi V; Nagy B; Gadó I; Milch H
Acta Microbiol Immunol Hung; 1994; 41(3):259-64. PubMed ID: 7697321
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of antibiotics used for enterohemorrhagic Escherichia coli O157 enteritis--effect of various antibiotics on extracellular release of verotoxin].
Ito T; Akino E; Hiramatsu K
Kansenshogaku Zasshi; 1997 Feb; 71(2):130-5. PubMed ID: 9077070
[TBL] [Abstract][Full Text] [Related]
20. Association of verotoxin-producing E. coli and verotoxin with hemolytic uremic syndrome.
Arbus GS
Kidney Int Suppl; 1997 Mar; 58():S91-6. PubMed ID: 9067954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
